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Background: The development of the evidence-base informing end of life (EoL) care is hampered by the
assumption that patients at the EoL are too vulnerable to participate in research. This study aims to systematically
and critically review the evidence regarding the experiences and views of patients, caregivers, professionals and
researchers about participation in EoL care research, and to identify best practices in research participation.
Methods: We searched seven electronic databases, and hand searched three journals and the bibliographies of
relevant papers. Inclusion criteria were original research papers on involvement in EoL care research or its impact
on participants. Critical interpretive synthesis was used to integrate the whole body of empirical evidence on this
topic and generate theoretical categories from the evidence.
Results: Of a total of 239 identified studies, 20 studies met the inclusion criteria, from: the US (11), the UK (6) and
Australia (3). Most focused on patients with cancer (12) and were conducted in hospices (9) or hospitals (7). Studies
enquired about issues related to: EoL care research in general (5), specific research methods (13), and trial research
(2). The studies evaluating willingness to participate in EoL care research showed positive outcomes across the
different parties involved in research. Factors influencing willingness were mainly physical and cognitive
impairment. Participating in research was a positive experience for most patients and carers but a minority
experienced distress. This was related to: characteristics of the participants; the type of research; or the way it was
conducted. Participatory study designs were found particularly suitable for enabling the inclusion of a wide range
of participants.
Conclusion: The evidence explored within this study demonstrates that the ethical concerns regarding patient
participation in EoL care research are often unjustified. However, research studies in EoL care require careful design
and execution that incorporates sensitivity to participants’ needs and concerns to enable their participation. An
innovative conceptual model for research participation relevant for potentially vulnerable people was developed.
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According to projections, the number of people aged 65 and
above will increase dramatically by 2030 (one in eight of the
global population) [1]. A demographic shift is occurring, with
people generally living longer and a smaller number dying
from infectious diseases [2]. This brings a different and cur-
rently not well-understood scenario - involving older people
suffering from chronic illnesses with complex and clinically
challenging trajectories. This rapidly changing situation will
create substantially greater end of life (EoL) care needs [3].
Within this paper, EoL care is understood in its broad-
est sense, referring to the care provided to people with
advanced, progressing and incurable disease and their
families. It covers the therapeutic approaches from diag-
nosis on, as well as the care provided at the very end of
life, during death and the bereavement process.
Deficiencies in EoL care have been reported, such as
in the area of pain and symptom management [3]. There
is a need for research involving patients at the end of
their lives in order to develop and test new treatments
and services and to ensure the provision of high-quality
and cost-effective care [4-7]. Numerous practical and
ethical obstacles to research during the EoL are well
documented [8,9]. Trial research is often hampered by
problems of recruitment, high attrition rates, missing
data and a lack of outcome measures validated with pal-
liative care patients [10].
The ethical arguments between the value of research and
the needs of patients are heavily debated and complex [11].
The debate reflects a community of stakeholders that is
polarised between those who argue that research within
this population is unjustified and those who argue that the
ethical principles that govern medical research are also
suitable to safeguard individuals’ interests to enable their
participation in EoL care research. While it is necessary to
consider the concerns of this debate there is little prospect
of resolving the existing tensions by argumentation alone.
Systematic reviews have appraised the evidence regarding
advanced cancer patients’ attitudes towards research [12]
and on palliative care patients’ and carers’ views about re-
search in palliative care [13]. This study broadens the
scope by undertaking a critical interpretive synthesis (CIS)
[14] across this field in order to synthesise existing empir-
ical data on the attitudes and values regarding participa-
tion held by all stakeholders involved in palliative care
research. Attention has been given to the methodological
issues that emerge from these studies.Aim
The study aims to appraise the evidence regarding all sta-
keholders’ views and experiences regarding involvement in
palliative care research and to explore whether there are
best practices regarding participation in research.Research questions
 Which stakeholders’ views on participation in
research are represented in the evidence and what
are the views held?
 Are patients and other stakeholders willing to
participate in EoL care research?
 How is participation in EoL care research
experienced?
 Are there differences in attitude according to group
(patient or other participants’ groups)?
 What are the best practices to enable patients’
participation in research on EoL care?
Methods
Design
We used CIS [14] to synthesise a diverse and complex
body of evidence consisting of both quantitative and
qualitative studies. This methodology incorporates pro-
cedures of conventional systematic review methodology
by applying explicit searching strategies to ensure replic-
able, specified inclusion criteria, and data extraction pro-
cedures to enhance clarity and comparability among
studies. This was combined with recent methods for in-
terpretive synthesis which drew on traditions of qualita-
tive enquiry. This combined approach enabled both
aggregation of the literature and the generation of theor-
etical categories that critically demonstrate the assump-
tions situated within the literature.
Search strategy
The search was conducted in four electronic databases:
MEDLINE (1950 – January week 2 2010); EMBASE
(1980 – January week 2 2010); PsycINFO (1806 – Janu-
ary week 2 2010); and CINAHL (1982 – January). Add-
itionally the following databases were searched for
relevant articles: Cochrane Database of Systematic
Reviews, The Cochrane Central Register of Controlled
Trials, Cochrane Pain, Palliative and Supportive Care
Trials Register.
The combination of search terms was piloted with a
number of trial searches to achieve a balance between
recall and specificity. A pre-defined search strategy was
decided upon, consisting of the following search terms,
representing three groups which were combined with
AND.
1. attitude$, OR view$, OR experience$, involv$, partic
$, perspect$, concern$, challeng$
2. research (Focus)
3. palliative care, OR palliat$, OR terminal, OR
terminally ill, OR supportive care, OR dying, OR
death, OR end of life, OR end-of-life, OR hospice,
OR bereavement.
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for further references. This was important as this topic
concerns a body of evidence, which is not well deli-
neated and is spread over the disparate research areas
that address palliative care.
Three journals, in which the debate regarding whether
or not to involve palliative care patients in research was
conducted, were hand searched. These were:
 The Journal of Pain and Symptom Management
(from 1999 to February 2010)
 Palliative Medicine (from 1989 to February 2010)
 Journal of Palliative Care (from 1985 to June 2010)
Inclusion and exclusion criteria
We included original research papers that enquired spe-
cifically about involvement in EoL care research or its
impact on participants. The participants included a wide
variety of stakeholders who come into contact with pal-
liative care research, including: patients, informal care-
givers, health professionals, managers, and researchers.
We included all research designs and searched across
the spectrum of palliative care from disease diagnosis to
death.
We excluded studies on oncology patients participat-
ing in trials testing curative treatments. We excluded
papers on children or adults with learning disabilities as
these areas have their own specific issues; and studies on
recruitment, informed consent, user involvement or be-












Figure 1 Flow chart.We did not include papers that were already included in
previous reviews. However, we investigated the individ-
ual studies in these reviews and included them if they
contributed to our review questions and responded to
our quality criteria. Fatally flawed studies were excluded.
To identify such low-quality studies we used the follow-
ing criteria (as specified in [14]):
 Are the aims and objectives of the research clearly
stated?
 Is the research design clearly specified and
appropriate for the aims and objectives?
 Do researchers provide a clear account of the
process by which their findings were produced?
 Do the researchers display enough data to support
their interpretations and conclusions?
 Is the method of analysis appropriate and adequately
explicated?Synthesis
First, the identified studies were mapped according to
country of origin, setting, participants, patient group, ill-
ness stage, and approach. The resultant studies were
then counted. Three major categories were identified:
studies that addressed issues relating to research in gen-
eral; research with specific methods; and trials. Within
these categories, studies were examined in more detail
and the results compared. This revealed areas that were
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plied to the literature across the categories. Results and
emerging queries were listed. Recommendations from
the studies were tabulated and organised inductively,
thereby generating information on best practices.
A third stage focused on the normative assumptions
underlying the studies and related these to the empirical
evidence they generated. The characteristics attributed
to ‘research’ and ‘care’ – and how these determined their
conceptualization – were critically assessed. Whether
the interpretation changed with each included study was
continually tested. The findings are synthesised as a con-
ceptual model for research participation for potentially
vulnerable people.
Results
Flow chart of search results
Please include Figure 1
The nature of the evidence
The characteristics of the studies are summarized in
Table 1 and Table 2. The evidence generated was of
three different types. Most studies (14) based their find-
ings on individuals’ directly reported experiences of par-
ticipating themselves in a research study. The other
studies approached the topic indirectly by enquiring
about attitudes [15,16], by enquiring about participants’
settled opinions or ways of thinking about research; or
asking hypothetical questions [17-20] to respondents
where they are asked about a supposed situation where
people who receive palliative care are invited to partici-
pate or are participating in research. These categories
are denoted in Table 2 as D (direct), A (attitudinal), and
H (hypothetical).
All the studies that enquired about attitudes to re-
search participation, or hypothetical research participa-
tion used prospective designs (6). The studies that
examined experiences of research participation used a
retrospective design (14). They either employed descrip-
tions of interventions or studies; analysed data recording
the research process (6) [21,22,25,32-34]; or a study was
nested within the primary study to examine participants’
experiences of the research process (8) [23,24,26-31].
Types of studies and their findings
Five studies considered participation in palliative care re-
search in general. Eleven studies enquired about issues
related to specific research methods that included ques-
tionnaires, qualitative interviews, focus groups, or obser-
vational and participatory methods. One study reported
on feedback to an observational design from epidemiology
or the social sciences [20]. Two studies assessed the views
of those involved in clinical trial research [17,34].Participation in research in general
The studies that assessed participation in research in
general reported willingness towards participation
mostly from hospice environments. Cassarett et al.
reported on a nation-wide telephone survey to define
the research that was conducted in hospices across the
US, to assess hospice organisations’ perceptions regard-
ing obstacles to research, and to identify their research
priorities. They found that participation in research was
related to hospice characteristics: urban location, aca-
demic affiliation, larger census and having an inpatient
unit. This raises concerns about the generalisability of
these results [16]. Kirsch et al. conducted a cross-
sectional anonymous survey with hospice staff to gain
insight into staff ’s attitudes, beliefs and values about re-
search with the patients they cared for and their families.
They found that staff were largely supportive of research,
but they acknowledged a mix of protectionism towards
patients and not having enough time for research as
Table 2 Research participation according to type of research
Study details Type of research Objectives Study design Assessment:
*D,H, A




[16] To define the research that is
conducted in hospices across
the US, assess perceptions of the
obstacles to research, and define
their views about the types of




A Hospice Organisations Prospective Hospice staff willing
to support research on:
Pain management, and
referral to hospice
[21] To describe the experiences in
establishing a designated










in turn facilitating teamwork
[22] Evaluation of data registry









collection at three months
and at 12 months
post-enrollment
D Hospital Cancer patients
at diagnosis
Retrospective The majority of newly
diagnosed patients
approached for
consent (68%) and their
primary family caregiver
(92%) were willing to
participate in the registry;
of these, 80% also agreed
to be contacted in the future
for additional studies.
Face-to-face interview was
the preferred method of
data collection. The majority
(about 70%) of newly
diagnosed adults with
cancer participated in a
data registry
[15] To examine hospice staff attitudes,
beliefs, values about research
with their patients, and family
Cross-sectional,
anonymous survey
A Hospice Staff Prospective Staff were largely
supportive of research
with patients and families
(mean agreement of 4.08-4.44).
They acknowledged a
mixture of being protective
(52% wanted to approach
the patients) and not having
enough time for research (59%
had no time or were willing
to spend no more than





















Table 2 Research participation according to type of research (Continued)
[18] To explore hypothetical interest in
research participation amongst




explore interest in survey
and therapeutic research




Prospective Hospice patients and carers
were interested: 46% and




were more likely to be
interested than older people.
No difference was found in
older hospice and
non-hospice patients
Research using surveys, interviews, observational and participatory methods
[23] To investigate the potential of
causing distress with
interview-based research
Patients participated in a
one-hour interview in
relation to their medical care.
They provided feedback
regarding the interview itself







[24] To reflect retrospectively on the
ethical aspects of a study on
patients with malignant
cerebral glioma, and the











5% did not like the
experience. There was




[25] To describe issues and dilemmas
related to nonparticipation,
attrition, and the need for
assistance in research with
vulnerable home hospice
participants
Mixed methods study with
home hospice patients with
mixed diagnoses. Retrospective
analysis, with descriptive
statistics of the frequency of
issues and dilemmas that
occurred in a research study
with a vulnerable population
D Hospice Patients, diagnosis
not specified
Retrospective From 113 potential
participants, 16 (14.1%)
people who gave initial
consent were unable to
participate or were lost
to the study (subset I)




































Table 2 Research participation according to type of research (Continued)
[26] Interviews and interviewed




patients and carers about
death, dying and bereavement:
stressful and/or helpful





87% of approached patients
and 97% of carers were
interviewed. Patients’ distress:
1.9% reported a great deal,
7.1% some, and 88% little or
no stress from the interview.
Carers’ distress: 1.5% reported
a great deal, 8.4% some, 89%
little or no stress. Slightly
more stress at re-interview.
Patients finding interview helpful:
16% very, 29% somewhat, 49%
little or not. Carers finding interview
helpful: 19% very, 34 somewhat,
44% little or not. The second
interview was seen as slightly
less helpful. People with pain,
more personal meaning in
dying and less at ease with
talking about dying reported
more stress. Patients from
ethnic minorities, anxious
about EoL, spiritual, serene
found interview helpful
[27] To explore patients’ and carers’
preferences and expectations
regarding their contribution to
research in palliative care
Qualitative interviews were
conducted in the context
of two studies on the






heart failure and MND
Retrospective
add-on
Differential patterns in decline
and acceptance of interviews
by patients with different
conditions and across settings
were found. Among cancer
patients, 21/51 declined;




end of life do want to
be offered the chance
to participate in research,
provided it is conducted
sensitively. Although such
research can be demanding,
most researchers believed it
to be no more problematic
than many other areas of
research and that the






















Table 2 Research participation according to type of research (Continued)
[28] To understand key challenges in
researching EoL issues and









sample of 32 researchers;
seven patients
with experience
of cancer; and four
carers
Prospective People affected by cancer and
researchers suggested
that many people nearing the
end of life do want to be
offered the chance to
participate in research,
provided it is conducted
sensitively. Although such
research can be demanding,
most researchers believed it
to be no more problematic
than many other areas of
research and that the
challenges identified can
be overcome
[29] To assess the burden
and benefits of participation
in psychosocial





















Reasons for refusal to an
observational study were
recorded verbatim and coded
using qualitative techniques





that they had more
to gain from participation.
Consenters felt that aches
or pain were more a
problem
[20] To explore the views and
preferences of patients
with advanced cancer





a study with cross-sectional
design
H Hospital Patients with
advanced cancer
Prospective Preferred health professional




in planning interviews is
important. Patients preferred
to be interviewed at home
but were prepared to take
part in hospital. Fluctuating
symptom control needs
may affect ability and
willingness
[31] To determine whether
caregivers believe that
interviews about EoL




increased risk of distress
Four studies approaching
families interviews Study 1:
mailed survey Study 2,3,4:
telephone survey





























Table 2 Research participation according to type of research (Continued)
[19] To investigate whether the
concerns researchers
have about including
terminally ill patients in research
were shared by a sample of
terminally ill patients
A descriptive qualitative analysis
of the views of hospice
patients on the problems of
carrying out research with
dying patients
H Hospice Terminally ill patients Prospective All the patients wanted to
participate in research.
Patients advanced one or
more of several reasons
for participation, the
commonest being altruism,
enhancement of a sense of
personal value, the assertion
of persisting autonomy and
the value they placed on a
commitment by doctors to
optimising care by research.
They rejected the view that
their consent might be
non-autonomous and put
forward consistent views
about what they considered
relevant to consent
[32] Experience of working with
co-researchers to collect data
from two hospices
The Macmillan Listening Study,
a UK-wide study exploring
research views and priorities
of people affected by cancer,
adopted a participatory
research approach. A total of
17 focus groups were held.












D Hospice Patients with advanced
illness and researcher
Retrospective They assess risk and benefits: patients
experiencing pain from discussing
sensitive issues. Patients can
sometimes open up more easily
to researchers than health
professionals. Researcher
experienced difficulties with
access to patients. The researcher
reflects on the impact of this
research on herself, recognising
sadness but also meaningfulness
Trial research
[34] To investigate the impact of a
three-year RCT of different
models of service provision
on staff
A qualitative substudy to a
large three-year RCT of different
models of service provision
on staff
D Hospice Palliative care staff Prospective Initially the impact of the trial
produced high levels of staff
stress, diminishing largely
over time, to be replaced by
enthusiasm for the changes
achieved and sadness that on
trial completion the perceived





















Table 2 Research participation according to type of research (Continued)
[17] To determine if patients with
advanced cancer are interested
in participation in research that
does not involve anti-cancer
therapy, particularly in the
context of a RCT, and if so,
what factors are important in
their decisions. What level of
inconvenience is tolerable and




H Hospital Patients with advanced
cancer and relatives
Prospective Patients with advanced cancer
are interested in participating
in RCTs focusing on symptom
control. Relatives are supportive
of participation. Over 75%
expressed altruistic views.
Many were prepared to complete
short questionnaires, accept extra
medications, investigations, hospital
visits or admissions within a trial
context. Deterrants: concepts of
‘randomisation’, ‘placebo-control’
and ‘blinding’, and the possibility
of side effects. Patients’ age was
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http://www.biomedcentral.com/1471-2288/12/123barriers to participation [15]. Williams et al. focused on
hospice patients and carers and compared their interest
in research with ambulatory senior citizens. The patients
and carers showed slightly lower interest in research
compared to senior citizens: in survey research, (45%
and 57%) and in therapeutic research (46% and 60%) re-
spectively [18].
Two other studies focused on a hospital setting. Daly
et al. showed the willingness of newly diagnosed cancer
patients (70%) to participate in psychosocial cancer re-
search through the evaluation of a data registry to ad-
vance research [22]. Christ et al. described the
establishment of a designated social work research unit
in a major academic cancer research institution. They
described the process of developing understanding and
collaboration among clinicians and researchers, which
required time and exposure to each other’s goals, values,
skills and limitations [21].
Participation in research using surveys, interviews,
observational or participatory methods
All except two studies [19,20] were evaluations of actual
research experiences and were retrospectively addressing
participation in research on EoL issues, which could in-
volve sensitive issues. Most studies made use of ques-
tionnaires and qualitative interviews or both, and two of
focus group discussions [19,32], of which one applied a
participatory approach [32]. One study reported on feed-
back to an observational design [30].
These studies were carried out in a variety of settings
and were all targeted at patients or their informal carers’
participation. In Kendall et al. a sample of researchers
was included [28].
The studies all reported a greater number of positive
than negative results. Where the two studies using a
hypothetical approach enquired about preferences
[19,20], the other studies either focused on patterns of
recruitment to uncover participants’ views on research
[24,27,30], or on the experiences of patients and carers
taking part in research that used social science method-
ology, or both [24-27].
Barnett showed that the majority of patients found a
one-hour long interview a positive, therapeutic experi-
ence [23]. In Davies et al. most patients (88%) and carers
(96%) agreed to be interviewed, while 63% reported
comfort from being interviewed and only 5% disliked
the experience. But they reported that there was a 95%
follow-up rate of the interviews [24]. In Emmanuel and
Emmanuel, 87% of approached patients and 97% of
carers were interviewed about death, dying and bereave-
ment. 88% of patients and of 89% carers reported little
or no stress from participating in an interview. The
results on helpfulness were more equivocal with 16% of
patients saying it was very helpful, 29% somewhat, 49%little or not, and 19% of carers saying it was very helpful,
34% somewhat, and 44% little or not [26].
Gysels et al. found differential patterns in decline and
acceptance of interviews by patients with different con-
ditions and across settings. Patients and carers were cap-
able of deciding whether to participate in interviews and
negotiate how they wanted this to happen [27]. Takesaka
et al. reported that 22% experienced distress due to
being interviewed about EoL issues [31]. Pessin et al.
showed that 75% of patients did not experience psycho-
social research as a burden, and 68% found it moderately
to highly beneficial [29]. Wright et al. assessed the in-
volvement of patients as co-researchers which did not
cause them distress, however some logistical and meth-
odological problems appeared [32]. A study from thana-
tology assessed risks and benefits associated with in-
depth interviewing. Patients found discussing sensitive
issues painful, but they said they benefitted by talking
with a researcher and thought they could do this more
openly than with a health professional. The researcher
reflected on the impact of this research on herself, and
recognized sadness but also meaningfulness [33]. In
Kendall et al., people affected by cancer and researchers
found that people nearing the EoL want to be offered
the chance to participate in research, provided it is con-
ducted sensitively [28]. Phipps et al. compared consent-
ing participants and refusers in observational research
and found that those participating thought they had
more to gain from research compared with refusers
(=0.04), and felt that pain was more of a problem
(p < 0.001) [30]. Dobratz et al. explored issues and dilem-
mas related to non-participation, attrition, and needs for
assistance in research with home hospice participants.
They found that 28.8% required assistance because of
physical impairments, and 14.1% were unable to partici-
pate or lost to the study because they suffered from cog-
nitive disturbance, and physical distress. Those who
completed testing expressed gratitude at being able to
contribute information that they believed would benefit
others [25].
One study that applied a hypothetical design explored
cancer patients’ views and preferences on taking part in
longitudinal questionnaire-based research studies. This
study shows the importance of flexibility in planning inter-
views as fluctuating symptoms may affect the ability and
willingness to participate in this population [20]. In a study
using hypothetical questions, patients very near to death
expressed a positive wish to participate in research [19].
Participation in clinical trials
Two studies were identified that considered research par-
ticipation in clinical trials. One was targeted at patients
with cancer and used a hypothetical approach [17] and one
at hospice staff obtained empirical data [34].
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ticipating in randomised controlled trials (RCTs) that
concerned symptom control and relatives supported
their participation in such trials. Over 75% of patients
expressed altruistic views as a reason for participation.
Many were prepared to complete short questionnaires,
accept extra medications, investigations, hospital visits
or admissions within a trial context. However deterrents
were: concepts of ‘randomisation’, ‘placebo-control’ and
‘blinding’, and the possibility of side-effects [17].
Grbich et al. documented the impact of a trial on hos-
pice staff which initially produced high levels of stress,
but diminished over time. The stress was replaced by en-
thusiasm for the achievements of the study and sadness
at the loss of benefits post-trial [34].
Characteristics of participants and the study designs
The included studies revealed various characteristics that
were either related to the individuals or groups investi-
gated or were associated with the specific area or type of
research.
Participant characteristics
Dobratz et al. provided insight into the problems com-
monly experienced by palliative care patients involved in
research. Cognitive disturbance, and physical distress
often played a role in attrition and in needing assistance
to enable participation [25]. This same finding was made
by Shipman et al. (see above) [20]. Phipps et al. com-
pared ‘consenters’ with ‘refusers’ (see above), showing
that consenters thought they had more to gain from re-
search and felt that aches or pain were more of a prob-
lem for them [30].
Williams showed that young people were more inter-
ested in taking part in research than older participants,
but there was no difference in attitudes between older
hospice and non-hospice patients [18]. Increasing age
also appeared in White et al. as the only negative factor
indicative of less involvement in trial research [17].
Gysels et al. showed differences in motivations to re-
search participation by patient groups, and between
patients and informal carers [27]. Takesake et al. showed
higher distress for women, younger carers and family
members of patients with cancer. They caution however
that although these associations were strong, the reasons
for them are uncertain [31].
Emmanuel and Emmanuel identified individual char-
acteristics of patients associated with the impact of a
research interview. People with pain, those who are
able to find more personal meaning in dying, and
being less at ease with talking about dying, were sig-
nificantly more likely to report more stress. Patients
from ethnic minorities, those who were anxious about
the end of life, and those who were more spiritual orserene were significantly more likely to find an inter-
view helpful [26].
Terry et al. showed that patients very close to death
provide unique understandings as death nears [19].
Study design characteristics
Cassarett et al. showed that hospice organisations were
more supportive of research that they considered to be
concerned with issues directly relevant to hospice care:
pain management and referral to a hospice [16]. Ship-
man et al. enquired about the best format with which to
conduct longitudinal studies using questionnaires.
Patients preferred health professionals known to them to
contact them about a study; they preferred face-to-face
interviews at home but they were prepared to take part
in them in hospital [20]. Face-to face interviews were
also the preferred method by patients in the studies by
Daly et al. and Terry et al. [19,22].
There is also evidence on the feasibility of conducting
interviews with carers and patients jointly or separately.
The study by Davies et al. outlined the disadvantages of
joint interviews [24], and Takesake et al. showed that
joint interviewing did not cause distress in the study’s
sample [31]. In three papers the benefit was shown of a
researcher who was not involved in the daily care of a
patient to whom patients could open up and give their
genuine view on events [24,27,33]. However, patients
experienced distress when asked to discuss death
[26,29].
Grbich et al. showed the potential to improve the con-
duct of a large RCT by carrying out a parallel qualitative
study [34].
Discussion
Willingness to participate in EoL research
All of the studies that evaluated willingness to partici-
pate in EoL care research showed positive outcomes
across the different parties involved [15-20,22,25,28].
The majority of patients were willing to take part in re-
search [15-20,22,25,28] and their informal carers were
supportive of this [17,18]. Also hospice staff and hospice
organizations were found to have positive attitudes to-
wards participating in research [15,16]. The studies that
reported on health professionals showed the most
equivocal results [15,34].
The studies illuminate the factors that influence will-
ingness to participate in research. Disability, physical dis-
tress and cognitive impairment formed barriers to
individuals’ participation in research studies. However,
some studies showed ways to enable patients to partici-
pate by providing assistance to complete questionnaires
and to use flexible and responsive approaches to data
collection to accommodate patients’ physical and cogni-
tive abilities [25]. Participation for patients was often
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through gratitude towards those who made it possible to
contribute [25].
Experiences of participating in EoL research
All 10 studies providing quantitative results showed that
participating in research at the EoL was a positive ex-
perience for the majority of patients and their carers
[20,23-27,29-32]. Benefits of participation were identi-
fied as being therapeutic or giving comfort, especially
in interviews [23,24,26,27] which provided the oppor-
tunity to reciprocate for good care, and to contribute
to service improvement. However, there was a minor-
ity who experienced involvement in research as dis-
tressing and this was related to either, characteristics
of the participants, the type of research, or the way it
was conducted.
The studies that evaluated actual experiences of re-
search participation provided particularly useful insights
on the benefits and risks of working with patients and
their carers at the EoL and suggest future directions for
research. The studies focusing on attitudes were helpful
in identifying participants’ beliefs and values about re-
search. Future attitude studies could widen their focus
and explore how these values are informed and used.
Studies that used hypothetical questions are important
in difficult-to-research areas but one needs to be aware
that they provide a normative view on reality. Most
studies have approached patients with a set of hypothet-
ical questions, particularly those involving trial research.
Examining actual experiences as patients go through
these trials – what motivated them, and the challenges
encountered – is likely to shed a different light on this.
Age appeared to be a factor that influenced attitudes
towards participation in research [17,18]. Differences
were found in the motivation to participate by patient
groups [27] and individual characteristics [26] and des-
pite the strong associations found in quantitative studies
there are no discernable explanations [31]. The identified
patterns of views and impacts of research require explor-
ation beyond the typical demographic variables, and
designs are needed to capture the complexity of con-
cerns and interactions between those involved in re-
search. A way forward is the development of mixed-
methods designs, which offer multiple opportunities to
verify data and its interpretation. However, these designs
require thorough planning from the outset and reflexiv-
ity in the way they are conducted. Palliative care encom-
passes those patients and carers at diagnosis through to
death and beyond, and as such longitudinal studies
could provide insight in to how levels of willingness and
experiences with research change throughout these
stages, and could help determine the best ways to con-
duct studies at different stages.Gaps in the evidence-base
We did not find any evidence of participation in re-
search from beyond the US, the UK or Australia. This
reflects the concentration of palliative care services and
research centres in these countries [6]. Studies from be-
yond the developed world will add to the findings from
this review and are expected to show how different
environments and values impact on attitudes and experi-
ences with research. This geographical bias also deter-
mined the study settings, which were mainly in-patient
hospices or hospitals. Other settings such as the home
and the community were under-represented.
The majority of the studies focused on patients with
cancer, while there were only a few studies that included
other advanced diseases. It is important to include the
range of diagnoses that have palliative care needs as dif-
ferent patient groups can have distinct concerns regard-
ing research. The gap in knowledge about cancer
patients in the advanced stages of illness seems to be
addressed since the review undertaken by Todd et al.
[12]. Most of the studies identified in this review tar-
geted the later stages of illness as concerns regarding re-
search were expected to become more pronounced
nearer to death. There were studies that did not pre-
cisely describe the stage of illness which is necessary to
compare experiences within the heterogeneous popula-
tion who require palliative care. Given the findings
regarding age as a significant influencing factor, future
studies could include older people.
As the ethical discussion about research participation
revolves for the most part around patient vulnerability,
the studies included here have mostly investigated pa-
tient views. A variety of other stakeholders were repre-
sented, but more evidence is needed about the roles they
fulfil and the particular contribution of each of these
parties. The views of members of ethics committees or
funders of EoL research were absent. Also studies that
focus on interactions between different stakeholders
could reveal perceived impacts of research, areas of con-
flict or opportunities for mutual understanding.
Research participation as teamwork
Several studies showed that research at the EoL is best
realised as a collaborative effort [21,24]. Division of tasks
between researchers and clinicians can lead to frequent
and extensive discussion that provides opportunities to
develop a realistic appreciation for each other’s capabil-
ities and limits [21]. Patients and other participants in
research need to be engaged as early as possible [15,35].
This requires a campaign of public education [32]
regarding the importance of research [36]. Health
professionals concerns also need to be addressed
[15,21,34,37,38]. Conditions conducive to research are
required, including: the sharing of skills, supportive
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providers and academic entities and extra resources
[32,34,38]. Flexibility is required in the policies, proto-
cols [34] and evaluations made by ethics committees in
order to counter administrative constraints and protect-
ive attitudes that often hinder research [40,41]. Research
in palliative care often requires mixed methods or a di-
version from standard procedures (for example when
dealing with informed consent), which are circumstances
that ethics committees are generally not used to working
with [40,41]. A ‘relational ethics’, where researchers and
ethics committees work in partnership, has therefore
been promoted as a suitable model to enable valid and
sensitive research in palliative care [40,41]. Participatory
designs were found particularly suitable to actively in-
clude a diversity of participants who can determine the
design and conduct of research [28,30,34,39].
Research with care
This review shows that the ethical concern about
patients at the EoL as too vulnerable to participate in re-
search is often unjustified. However, the studies provid-
ing evidence about participation in research should not
simply dismiss these concerns that have grown through
debate and argumentation in ethics. Rather, they need to
put these side by side and critically assess how the find-
ings can inform the best way forward. Therefore, we
analysed the rationale that underlies the reasoning about
research in EoL care. We investigated the normative
framework that organises the problematic issues pertain-
ing to EoL care research from the entire body of evi-
dence. The resulting conceptual model frames our
understanding about what research is and does in EoL
care settings. The model shows the ‘taken for granted’
knowledge on which respondents base their actions and
develop their attitudes.
The ethical arguments frame research and care as if they
have oppositional goals and values (see Figure 2). This is
what is called the deontological-utilitarian conflict where









Figure 2 Oppositional values of research and care at the EoL.balanced against the goal of ensuring optimal comfort and
benefit [42]. People should in other words not be sub-
jected to greater risk than what they would endure in rou-
tine assessment or treatment. Research is understood as
instrumental, using the patient and others taking part in
it, as a means to an end. Care, on the other hand, has the
best interests of the patient and others in mind. Research
is for the benefit of future patients, as it is argued that
patients will already have died by the time that the find-
ings will have materialised in interventions, while care can
be provided immediately and directly. Within this dis-
course, research is perceived as active, and those who par-
ticipate in it as passive, as the latter are presented as being
subjected to research. It is objective, and removed, while
care is personal and close. Stakeholders representing dif-
ferent territories should stay on their own sides to avoid
misunderstandings. Researchers who transgress these
boundaries of research and care – for example, those who
collect data through qualitative methods, which inevitably
involves close communication and empathy, are told to
take all precautions to protect patients from deception. In
the same way, the clinician-scientist is challenged as in-
appropriate, as this could lead to coercion based on the
trust developed between the health professional and
the person being cared for. The opposition is reflected in
the metaphors attached to these domains where positions
are crystallised in terms of ‘warm’ care and ‘cold’ research.
Where objections to research were expressed in the
studies under review, these came from the concern that
research would detrimentally affect the care that patients
need. For example, the protective attitudes by hospice staff
towards their patients in Kirsch et al. [15] gave evidence of
such a concern, or the apprehension patients expressed
towards terms associated with trial research in White
et al. [17], where terms such as ‘randomisation’, ‘placebo-
control’ and ‘blinding’ deterred patients from participating
in research. This reflects similar concerns found in an
earlier study of patients’ and the public’s view of the
process of randomisation, where the role of chance by
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cation in the context of life-threatening research, and were
found to be upsetting and trivialising [43].
Successful studies were the result of research that was
conducted with care, with for example tailored data col-
lection to accommodate patients’ disabilities and to en-
able their participation [25]. The studies using a
participatory design were also based on mutual recogni-
tion of each other’s strengths and weaknesses and were
conducted within a teamwork-based setting [17]. Such
studies suggest that a different model of research in EoL
care is needed (see Figure 3). When research is
embraced by care, many of the ethical objections be-
come invalid. The issue of being used as a means to an
end, or in other words as a mere instrument for research
goals, does not apply any longer when research is
embraced by care. A collaborative model with equal in-
put of all the parties involved in research, who share a
concern to care will lead to sensitivity to the needs that
arise during the conduct of research studies. This also
guarantees the immediate benefits that involvement
holds for patients, such as empowerment, self-validation
or the opportunity it offers for altruism [13,19]. A rela-
tional approach where the ideas of different stakeholders
from a diversity of disciplines are exchanged, can lead to
an intersubjective view on what is investigated and the
way research is conducted. The concern about granting












Figure 3 Research with care.responsibility among those involved and is realised
through open dialogue. The attention then focuses on
what support and supervision is needed in order to opti-
mise participants’ contributions [8,17] and this can lead
to a change in culture in terms of attitudes towards re-
search [21,34].
Limitations
This paper set out to systematically assess the evidence
relating to barriers and solutions to participation in re-
search at the EoL. However the review is limited as only
original research studies were included. Papers present-
ing ethical debates on participation within EoL care re-
search were excluded. For a comprehensive overview of
the field, the ethical arguments need to be read along-
side this review. It is also possible that the gaps identi-
fied in the evidence-base are not neutral with regard to
the aim of the study, and that they represent an indica-
tion for undetected problems in EoL research, which can
lead to publication bias.
Conclusion
This review provides an evidence-base about ethical
concerns regarding research at the EoL. Although the
literature focused most on patients with cancer, a range
of other participant groups were also represented, such
as health professionals, carers and researchers. The evi-
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most likely to have concerns about involving patients at
the EoL were health professionals.
This review showed that the ethical concerns regard-
ing patient participation in EoL care research are often
not justified. Patients are generally willing to contribute
to research and the majority of those who take part in
research, report it as a positive experience. Patients con-
firm that it brings them direct benefits. However, there
was a minority of people for whom taking part caused
distress, requiring increased sensitivity to individuals’
changing needs and circumstances. Assistance needs to
be in place for such situations. The palliative care popu-
lation commonly experience fluctuating symptoms
across their disease trajectory, which can cause varying
levels of physical and cognitive impairment. Therefore,
research needs to be flexible and equipped with methods
that can enable patients and carers to participate in re-
search on EoL care.
Denying patients the opportunity to participate in re-
search on the basis of an a priori label of vulnerability is
paternalistic. Given the diversity of this population,
patients need to be approached as individuals, to assess
whether it is desirable to involve them in research. This
makes the model presented here not only applicable to
the EoL population, but to all potentially vulnerable
people.
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